ei2024-vcpanel600x200
April 18, 2024
Recent News
- RefloDx Wins Trans Atlantic Angel Grand Prize
- Webinar Recap: Immigration Compliance Under Pressure
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
